Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc.verified

HARP

Price:

$23.01

Market Cap:

$865.08M

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic c...[Read more]

Industry

Biotechnology

IPO Date

2019-02-08

Stock Exchange

NASDAQ

Ticker

HARP

The PE Ratio as of June 2024 (TTM) for Harpoon Therapeutics, Inc. (HARP) is -15.04

According to Harpoon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.04. This represents a change of -1958.73% compared to the average of 0.81 of the last 4 quarters.

Harpoon Therapeutics, Inc. (HARP) Historical PE Ratio (quarterly & annually)

How has HARP PE Ratio performed in the past?

The mean historical PE Ratio of Harpoon Therapeutics, Inc. over the last ten years is -21.17. The current -15.04 PE Ratio has changed 7.00% with respect to the historical average. Over the past ten years (40 quarters), HARP's PE Ratio was at its highest in in the June 2023 quarter at 6.35. The PE Ratio was at its lowest in in the December 2017 quarter at -64.55.

Quarterly (TTM)
Annual

Average

-21.17

Median

-7.58

Minimum

-111.83

Maximum

-0.36

Harpoon Therapeutics, Inc. (HARP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Harpoon Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 55.63%

Maximum Annual PE Ratio = -0.36

Minimum Annual Increase = -93.22%

Minimum Annual PE Ratio = -111.83

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.36-75.50%
2021-1.46-83.67%
2020-8.9744.95%
2019-6.19-47.56%
2018-11.7955.63%
2017-7.58-93.22%

Harpoon Therapeutics, Inc. (HARP) Average PE Ratio

How has HARP PE Ratio performed in the past?

The current PE Ratio of Harpoon Therapeutics, Inc. (HARP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.60

5-year avg

-5.75

10-year avg

-21.17

Harpoon Therapeutics, Inc. (HARP) PE Ratio vs. Peers

How is HARP’s PE Ratio compared to its peers?

Harpoon Therapeutics, Inc.’s PE Ratio is less than Passage Bio, Inc. (-0.64), less than Black Diamond Therapeutics, Inc. (-3.45), less than TCR2 Therapeutics Inc. (-0.44), less than Alector, Inc. (-3.31), less than Stoke Therapeutics, Inc. (-6.42), less than Homology Medicines, Inc. (-0.01), less than Adaptimmune Therapeutics plc (0), less than Revolution Medicines, Inc. (-1.30), less than Atreca, Inc. (-12.83), less than null (-0.04),

Build a custom stock screener for Harpoon Therapeutics, Inc. (HARP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harpoon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harpoon Therapeutics, Inc. (HARP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harpoon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Harpoon Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Harpoon Therapeutics, Inc. (HARP)?

What is the highest PE Ratio for Harpoon Therapeutics, Inc. (HARP)?

What is the 3-year average PE Ratio for Harpoon Therapeutics, Inc. (HARP)?

What is the 5-year average PE Ratio for Harpoon Therapeutics, Inc. (HARP)?

How does the current PE Ratio for Harpoon Therapeutics, Inc. (HARP) compare to its historical average?